Satoru Oshino Selected Research

Satoru Oshino Research Topics

Disease

11	Pain (Aches) 10/2022 - 05/2006
6	Neuralgia (Stump Neuralgia) 01/2022 - 02/2010
5	Parkinson Disease (Parkinson's Disease) 11/2018 - 01/2008
4	Neoplasms (Cancer) 06/2016 - 10/2003
3	Partial Epilepsies (Epilepsy, Partial) 01/2022 - 01/2021
3	Epilepsy (Aura) 11/2021 - 01/2013
3	Tremor (Tremors) 07/2021 - 08/2007
2	Spinal Cord Injuries (Spinal Cord Injury) 09/2023 - 02/2010
2	Seizures (Absence Seizure) 01/2021 - 01/2021
2	Acromegaly 01/2019 - 02/2015
2	Aneurysm (Aneurysms) 12/2016 - 06/2013
2	Pituitary Neoplasms (Pituitary Adenoma) 01/2016 - 08/2012
2	Temporal Lobe Epilepsy 08/2015 - 02/2013
2	Bone Resorption 01/2015 - 01/2014
2	Adenoma (Adenomas) 08/2012 - 02/2006
2	Causalgia (Syndrome, Causalgia) 09/2007 - 05/2006
1	Cerebral Palsy (Spastic Diplegia) 09/2023
1	Disease Progression 09/2023
1	Hereditary Spastic Paraplegia 09/2023
1	Aspergillosis 01/2023
1	Emergence Delirium 06/2018
1	Atrophy 06/2018
1	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 12/2016
1	Quadriplegia (Spastic Quadriplegia) 08/2016
1	Pituitary ACTH Hypersecretion 06/2016
1	ACTH-Secreting Pituitary Adenoma 06/2016
1	Dyslipidemias (Dyslipidemia) 01/2016
1	Glucose Intolerance 01/2016
1	Hypertension (High Blood Pressure) 01/2016
1	Cushing Syndrome 01/2016
1	Type 2 Diabetes Mellitus (MODY) 02/2015
1	Diabetes Mellitus 02/2015
1	Growth hormone excess 02/2015
1	Complex Regional Pain Syndromes 02/2010
1	Cerebral Hemorrhage 02/2010
1	Infarction (Infarctions) 02/2010
1	Intractable Pain 02/2010
1	Failed Back Surgery Syndrome 02/2010
1	Stroke (Strokes) 12/2008
1	Dyskinesias (Dyskinesia) 01/2008
1	Growth Hormone-Secreting Pituitary Adenoma 02/2006
1	Neurilemmoma (Schwannoma) 10/2003
1	Lymphoma (Lymphomas) 10/2003

Drug/Important Bio-Agent (IBA)

5	salicylhydroxamic acid (SHAM)IBA 01/2022 - 09/2007
4	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2014
4	Growth Hormone (Somatotropin)IBA 12/2016 - 02/2006
2	Baclofen FDA LinkGeneric 09/2023 - 08/2016
2	Analgesics (Analgesic Drugs)IBA 01/2022 - 01/2021
2	Insulin-Like Growth Factor I (IGF-1)IBA 01/2019 - 12/2016
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 02/2015
2	Adrenocorticotropic Hormone (ACTH)FDA Link 06/2016 - 01/2016
2	collagen type I trimeric cross-linked peptideIBA 01/2015 - 01/2014
2	Alkaline PhosphataseIBA 01/2015 - 01/2014
2	Collagen Type I (Type I Collagen)IBA 01/2015 - 01/2014
1	Voriconazole (Vfend)FDA LinkGeneric 01/2023
1	PlasticsIBA 11/2018
1	Pro-Opiomelanocortin (Proopiomelanocortin)IBA 06/2016
1	Proteins (Proteins, Gene)FDA Link 06/2016
1	Proprotein Convertase 1IBA 06/2016
1	Transcription Factors (Transcription Factor)IBA 06/2016
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 06/2016
1	EnzymesIBA 06/2016
1	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 06/2016
1	Peptides (Polypeptides)IBA 06/2016
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2016
1	Hydrocortisone (Cortisol)FDA LinkGeneric 01/2016
1	GlucocorticoidsIBA 01/2016
1	Vasopressins (Vasopressin)IBA 01/2016
1	Deamino Arginine Vasopressin (Desmopressin)FDA LinkGeneric 01/2016
1	Kainic Acid (Kainate)IBA 08/2015
1	AlbuminsIBA 02/2015
1	Therapeutic UsesIBA 02/2014
1	Insulin-Like PeptidesIBA 06/2013
1	iomazenilIBA 02/2013
1	Thyrotropin-Releasing Hormone (Protirelin)FDA Link 08/2012
1	Keratins (Keratin)IBA 08/2012
1	Levodopa (L Dopa)FDA LinkGeneric 08/2007
1	Insulin (Novolin)FDA Link 02/2006
1	Bromocriptine (Parlodel)FDA LinkGeneric 02/2006
1	Octreotide (Sandostatin)FDA LinkGeneric 02/2006

Therapy/Procedure

10	Transcranial Magnetic Stimulation 01/2022 - 05/2006
4	Therapeutics 01/2023 - 10/2003
4	Spinal Cord Stimulation 10/2022 - 02/2010
4	Electrodes (Electrode) 01/2022 - 01/2021
3	Deep Brain Stimulation 07/2021 - 01/2008
2	Operative Surgical Procedures 06/2018 - 01/2013
1	Neurofeedback 11/2018
1	Glycemic Control 02/2015
1	Activities of Daily Living (ADL) 01/2008
1	Electric Stimulation Therapy (Electrotherapy) 05/2006
1	Drug Therapy (Chemotherapy) 10/2003
1	Radiotherapy 10/2003